301 related articles for article (PubMed ID: 34655743)
21. Exosomal microRNAs in liquid biopsies: future biomarkers for prostate cancer.
Valentino A; Reclusa P; Sirera R; Giallombardo M; Camps C; Pauwels P; Crispi S; Rolfo C
Clin Transl Oncol; 2017 Jun; 19(6):651-657. PubMed ID: 28054319
[TBL] [Abstract][Full Text] [Related]
22. Role of exosomes in prostate cancer bone metastasis.
Lv T; Li Z; Wang D; Guo X; Zhang X; Cao J; Wang Z
Arch Biochem Biophys; 2023 Oct; 748():109784. PubMed ID: 37816420
[TBL] [Abstract][Full Text] [Related]
23. MicroRNAs in extracellular vesicles: potential cancer biomarkers.
Kinoshita T; Yip KW; Spence T; Liu FF
J Hum Genet; 2017 Jan; 62(1):67-74. PubMed ID: 27383658
[TBL] [Abstract][Full Text] [Related]
24. Circulating Y-RNAs in Extracellular Vesicles and Ribonucleoprotein Complexes; Implications for the Immune System.
Driedonks TAP; Nolte-'t Hoen ENM
Front Immunol; 2018; 9():3164. PubMed ID: 30697216
[TBL] [Abstract][Full Text] [Related]
25. Emerging Role of Extracellular Vesicles in Prostate Cancer.
Ludwig M; Rajvansh R; Drake JM
Endocrinology; 2021 Sep; 162(9):. PubMed ID: 34232289
[TBL] [Abstract][Full Text] [Related]
26. Circulating RNAs in prostate cancer patients.
Mugoni V; Ciani Y; Nardella C; Demichelis F
Cancer Lett; 2022 Jan; 524():57-69. PubMed ID: 34656688
[TBL] [Abstract][Full Text] [Related]
27. Role of extracellular vesicles in castration-resistant prostate cancer.
Liao C; Huang Z; Liu J; Deng M; Wang L; Chen Y; Li J; Zhao J; Luo X; Zhu J; Wu Q; Fu W; Sun B; Zheng J
Crit Rev Oncol Hematol; 2024 May; 197():104348. PubMed ID: 38588967
[TBL] [Abstract][Full Text] [Related]
28. miRNAs in prostate cancer: Intercellular and extracellular communications.
Urabe F; Yamamoto Y; Kimura T
Int J Urol; 2022 Dec; 29(12):1429-1438. PubMed ID: 36122303
[TBL] [Abstract][Full Text] [Related]
29. Transcriptomic profiling of urine extracellular vesicles reveals alterations of CDH3 in prostate cancer.
Royo F; Zuñiga-Garcia P; Torrano V; Loizaga A; Sanchez-Mosquera P; Ugalde-Olano A; González E; Cortazar AR; Palomo L; Fernández-Ruiz S; Lacasa-Viscasillas I; Berdasco M; Sutherland JD; Barrio R; Zabala-Letona A; Martín-Martín N; Arruabarrena-Aristorena A; Valcarcel-Jimenez L; Caro-Maldonado A; Gonzalez-Tampan J; Cachi-Fuentes G; Esteller M; Aransay AM; Unda M; Falcón-Pérez JM; Carracedo A
Oncotarget; 2016 Feb; 7(6):6835-46. PubMed ID: 26771841
[TBL] [Abstract][Full Text] [Related]
30. Clinical utility of emerging biomarkers in prostate cancer liquid biopsies.
Boerrigter E; Groen LN; Van Erp NP; Verhaegh GW; Schalken JA
Expert Rev Mol Diagn; 2020 Feb; 20(2):219-230. PubMed ID: 31577907
[No Abstract] [Full Text] [Related]
31. An integrated workflow for biomarker development using microRNAs in extracellular vesicles for cancer precision medicine.
Chen Y; Wu T; Zhu Z; Huang H; Zhang L; Goel A; Yang M; Wang X
Semin Cancer Biol; 2021 Sep; 74():134-155. PubMed ID: 33766650
[TBL] [Abstract][Full Text] [Related]
32. [Exosomes in the diagnosis of prostate cancer: Advances in studies].
Zhao XD; Chen YQ; Liu Z; Xu S
Zhonghua Nan Ke Xue; 2022 Dec; 28(12):1123-1128. PubMed ID: 37846634
[TBL] [Abstract][Full Text] [Related]
33. miR-26a regulates extracellular vesicle secretion from prostate cancer cells via targeting SHC4, PFDN4, and CHORDC1.
Urabe F; Kosaka N; Sawa Y; Yamamoto Y; Ito K; Yamamoto T; Kimura T; Egawa S; Ochiya T
Sci Adv; 2020 May; 6(18):eaay3051. PubMed ID: 32494663
[TBL] [Abstract][Full Text] [Related]
34. Enhanced shedding of extracellular vesicles from amoeboid prostate cancer cells: potential effects on the tumor microenvironment.
Kim J; Morley S; Le M; Bedoret D; Umetsu DT; Di Vizio D; Freeman MR
Cancer Biol Ther; 2014 Apr; 15(4):409-18. PubMed ID: 24423651
[TBL] [Abstract][Full Text] [Related]
35. Detection of circulating miRNAs: comparative analysis of extracellular vesicle-incorporated miRNAs and cell-free miRNAs in whole plasma of prostate cancer patients.
Endzeliņš E; Berger A; Melne V; Bajo-Santos C; Soboļevska K; Ābols A; Rodriguez M; Šantare D; Rudņickiha A; Lietuvietis V; Llorente A; Linē A
BMC Cancer; 2017 Nov; 17(1):730. PubMed ID: 29121858
[TBL] [Abstract][Full Text] [Related]
36. Tumor-derived extracellular vesicles: reliable tools for Cancer diagnosis and clinical applications.
Rahbarghazi R; Jabbari N; Sani NA; Asghari R; Salimi L; Kalashani SA; Feghhi M; Etemadi T; Akbariazar E; Mahmoudi M; Rezaie J
Cell Commun Signal; 2019 Jul; 17(1):73. PubMed ID: 31291956
[TBL] [Abstract][Full Text] [Related]
37. Extracellular vesicle communication pathways as regulatory targets of oncogenic transformation.
Choi D; Lee TH; Spinelli C; Chennakrishnaiah S; D'Asti E; Rak J
Semin Cell Dev Biol; 2017 Jul; 67():11-22. PubMed ID: 28077296
[TBL] [Abstract][Full Text] [Related]
38. Tumor-associated macrophages promote prostate cancer progression via exosome-mediated miR-95 transfer.
Guan H; Peng R; Fang F; Mao L; Chen Z; Yang S; Dai C; Wu H; Wang C; Feng N; Xu B; Chen M
J Cell Physiol; 2020 Dec; 235(12):9729-9742. PubMed ID: 32406953
[TBL] [Abstract][Full Text] [Related]
39. Extracellular vesicles in cancer: exosomes, microvesicles and the emerging role of large oncosomes.
Minciacchi VR; Freeman MR; Di Vizio D
Semin Cell Dev Biol; 2015 Apr; 40():41-51. PubMed ID: 25721812
[TBL] [Abstract][Full Text] [Related]
40. Different gDNA content in the subpopulations of prostate cancer extracellular vesicles: apoptotic bodies, microvesicles, and exosomes.
Lázaro-Ibáñez E; Sanz-Garcia A; Visakorpi T; Escobedo-Lucea C; Siljander P; Ayuso-Sacido A; Yliperttula M
Prostate; 2014 Oct; 74(14):1379-90. PubMed ID: 25111183
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
